Mizuho Maintains FMC Rating, Lowers Price Target to $20.00 | FMC Stock News
Mizuho analyst Edlain Rodriguez has maintained an "Outperform" rating on FMC but lowered the price target from $21.00 to $20.00. This adjustment reflects a cautious outlook among analysts, with several recent price target reductions from other firms like Citigroup, Wells Fargo, and RBC Capital. Despite the lowered price target, the average analyst target price for FMC is $21.63, suggesting an upside of 50.83% from its current price, while GuruFocus estimates a fair value of $47.67, indicating a potential upside of 232.43%.
FMC price target lowered to $20 from $21 at Mizuho
Mizuho analyst Edlain Rodriguez has lowered the price target for FMC (FMC) to $20 from $21 while maintaining an Outperform rating on the shares. This adjustment comes after the firm updated the company's model following its recent earnings report. Other analysts from Citi, BofA, Morgan Stanley, and RBC Capital have also recently reduced their price targets for FMC.
Lessons for Life | Olivia Pfeiffer
Olivia Pfeiffer, a Villanova University alumna with a double major in Economics and Humanities and a minor in Sustainability, found her dream job as the first environmental, social, and governance specialist at a chemical manufacturing company. She credits her Humanities education for equipping her with critical thinking skills to navigate the uncertainties of her role. In gratitude, Pfeiffer helped establish the Great Books Fund to provide free books to Humanities students, raising nearly $10,000.
Mizuho Securities Maintains FMC Corp(FMC.US) With Buy Rating, Cuts Target Price to $20
Mizuho Securities has reaffirmed its "Buy" rating for FMC Corp (FMC.US) but has adjusted its target price downwards from $21 to $20. According to TipRanks data, the analyst, Edlain Rodriguez, has a 69.4% success rate and an average return of 10.4% over the past year. This rating adjustment provides an update on analyst sentiment regarding FMC Corp's stock performance.
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip
The provided content is empty and does not contain any article text. Therefore, a summary cannot be generated.
FMC Corp.: How a Quiet Chemistry Powerhouse Became a Strategic Tech Product in Global Food Security
FMC Corp. has transformed itself from a traditional chemical company into a technology platform for precision crop protection, integrating proprietary chemistries, advanced formulations, biological solutions, and digital tools. This strategic shift positions FMC as a resilience provider in global food security, competing with larger agricultural giants by offering an integrated product ecosystem rather than just chemical products. The company's focus on innovation, resistance management, regulatory alignment, and data integration aims to drive long-term value and growth, enabling it to be viewed as a strategic asset rather than a cyclical commodity stock.
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale
FMC Corp., based in University City, Philadelphia, is exploring a potential sale and strategic review after reporting a $2.24 billion net loss in 2025, sharply down from a $342 million profit in 2024. The company's board has authorized the search for a buyer and other options to improve its prospects and strengthen its balance sheet, including asset sales and licensing agreements to manage its $1 billion debt. CEO Pierre Brondeau hopes these steps will ensure the future success of its products, like the insecticide Rynaxypyr.
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip
The article discusses FMC Corporation's Q4 earnings miss and its projection of tariff challenges impacting Q1. This indicates a challenging start to the year for the agricultural sciences company, despite its efforts in the market.
FMC Weighs Full Sale As Debt Pressures And Patent Risks Mount
FMC (NYSE:FMC) is considering a full company sale and has engaged advisors to explore broad options for its future, alongside ongoing plans to sell its Indian business and reduce debt. This strategic review is a response to recent credit rating downgrades and the impact of patent expirations. The move signals a potential major shift for the company, as it faces financial challenges including a 2025 net loss and high leverage, requiring careful attention from investors regarding ownership structure and future cash flows.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference
FMC Corporation announced that its CEO, Pierre Brondeau, and CFO, Andrew Sandifer, will speak at the Bank of America Global Agriculture and Materials Conference on February 25, 2026, at 2:45 p.m. Eastern Time. A live webcast of their presentation will be available for interested parties. FMC is a global agricultural sciences company focused on providing innovative crop protection solutions.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference
FMC Corporation announced that CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the Bank of America Global Agriculture and Materials conference on February 25, 2026, at 2:45 p.m. ET. A live webcast of their presentation will be available for investors on the company's website. FMC Corporation is a global agricultural sciences company focused on crop protection solutions.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference
FMC Corporation announced that its CEO, Pierre Brondeau, and CFO, Andrew Sandifer, will speak at the Bank of America Global Agriculture and Materials conference on February 25, 2026, at 2:45 p.m. Eastern Time. A live webcast of their presentation will be available for public access. FMC Corporation is an agricultural sciences company focused on providing crop protection solutions.
FMC (FMC) Expects Tariff Headwinds for Q1 as Q4 Earnings Slip
FMC Corporation (FMC) reported a significant decline in Q4 2025 earnings and revenue, with adjusted EPS down 33% and sales down 11% year over year. The company projects further decreases for Q1 2026, partly due to expected tariff headwinds of approximately $20 million. Moody's recently downgraded FMC's rating to junk status, citing challenges from patent expirations on its Rynaxypyr product.
FMC (FMC) Expects Tariff Headwinds for Q1 as Q4 Earnings Slip
FMC Corp. (FMC) reported a significant slip in its Q4 2025 earnings and projects further declines in Q1 2026 sales and EBITDA, largely due to tariff headwinds and one-off costs. The company also faces a recent downgrade to "junk status" by Moody's due to patent expirations. Despite these challenges, FMC aims to reduce its debt by over $1 billion through asset sales and licenses in 2026.
FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut
FMC Corporation's shares jumped nearly 7% in morning trading, reaching $16.46, as traders reacted to the ongoing strategic review that could lead to a sale of the company. This comes despite Citigroup maintaining a "Neutral" rating and trimming its price target for FMC to $14 from $16. The company is also battling pricing pressure, navigating post-patent challenges for its key insecticide, and facing a Moody's downgrade of its senior unsecured ratings to junk.
Breaking Down FMC: 11 Analysts Share Their Views
Eleven analysts have shared their views on FMC (NYSE: FMC) over the past three months, resulting in an average price target of $15.91, a 24.24% decrease from the previous average. While the company showed strong revenue growth of 99.8% in the last quarter of 2025, its net margin, Return on Equity, and Return on Assets are below industry standards, and its debt-to-equity ratio is high. Analysts generally hold an "Indifferent" stance, with many lowering their price targets.
FMC Corp Earnings Call Maps Difficult Transition Year
FMC Corp's recent Q4 earnings call revealed a challenging transition year ahead, marked by lower revenue guidance, an expected sharp drop in Q1 EBITDA, and ongoing competitiveness issues. Despite these hurdles, management outlined a strategic review that includes the possibility of a company sale, aggressive debt reduction plans, and continued investment in high-growth new active ingredients. The company aims to restore growth and shareholder value by 2027-2028 through significant restructuring and cost-cutting initiatives.
FMC Corporation (FMC): A Bull Case Theory
This article summarizes a bullish thesis on FMC Corporation, an agricultural sciences company that has experienced a significant sell-off. Despite recent challenges like an 83% dividend cut and agricultural demand weakness, the underlying business is described as operationally sound. The bull case hinges on an eventual recovery in the agricultural cycle and successful debt reduction, presenting a potential deep-value opportunity.
FMC Corporation (NYSE:FMC) Q4 2025 Earnings Call Transcript
FMC Corporation (NYSE:FMC) held its Q4 2025 earnings call, discussing results, 2026 priorities, and the exploration of strategic options, including a potential sale of the company. The company aims to strengthen its balance sheet by reducing over $1 billion in debt through asset sales and licensing agreements, improve the competitiveness of its core off-patent portfolio, manage a post-patent Rynaxypyr strategy, and drive growth in new active ingredients. Despite a challenging market and expected bottoming out in 2026, FMC anticipates EBITDA growth in mid-teens for 2027 and 2028, driven by its growth portfolio and cost-reduction initiatives.
FMC Considering Asset Sales or Potential Sale of Company to Reduce Debt
FMC Corporation is exploring options including asset sales, licensing, or a potential sale of the company to reduce debt. This strategic review comes after a multiyear downturn and patent expirations for its key crop protection products. The company has historically built its portfolio through acquisitions, including Cheminova and DuPont's crop chemical business, while divesting non-agriculture assets.
FMC Corp. to explore strategic options, including possible sale
FMC Corp. announced it is exploring a range of strategic options, including a possible sale of the company. This move comes as the company seeks to enhance shareholder value and optimize its business structure. The exploration of options could lead to various outcomes, ensuring all avenues for growth and value creation are considered.
FMC Corp. explores sale following $2.2B loss
FMC Corp. is reportedly exploring a sale following a significant $2.2 billion loss. The potential sale could introduce a new company to Philadelphia's skyline, as FMC Corp. is headquartered in the FMC Tower in University City. The article suggests this development could impact the local business landscape.
FMC: Fourth Quarter Earnings Overview
FMC Corp. reported a significant net loss of $1.72 billion for the fourth quarter, with adjusted earnings of $1.20 per share, slightly missing analyst expectations. Revenue for the quarter was $1.08 billion, also below Wall Street forecasts. For the full year, the company had a total loss of $2.24 billion on $3.47 billion in revenue, and it provided guidance for both the first quarter and full year 2026.
FMC: Fourth Quarter Earnings Overview
FMC Corp. reported a significant net loss of $1.72 billion, or $13.74 per share, for the fourth quarter, with adjusted earnings of $1.20 per share falling slightly short of analyst expectations. Their quarterly revenue of $1.08 billion also missed Wall Street forecasts. For the upcoming first quarter, FMC anticipates a per-share loss and a revenue range below analyst expectations, and full-year earnings and revenue projections also reflect ongoing challenges.
FMC: Q4 Earnings Snapshot
FMC Corp. (FMC) reported a significant loss of $1.72 billion, or $13.74 per share, in its fourth quarter, falling short of Wall Street's earnings and revenue expectations. Adjusted earnings were $1.20 per share, while revenue was $1.08 billion for the period. The company also provided guidance for the upcoming quarter and the full year, anticipating a continued loss per share and revenue in the range of $3.6 billion to $3.8 billion for the full year.
FMC weighs company sale after $2.24B annual loss and $1B debt-cut plan
FMC Corporation is exploring strategic options, including a potential sale of the company, following a significant 2025 net loss of $2.24 billion, primarily due to a non-cash goodwill impairment. The company also announced 2026 priorities, including a plan to pay down $1 billion in debt through asset sales and licensing agreements, and provided financial guidance projecting decreased revenue and Adjusted EBITDA for 2026. This announcement led to a moderate negative market reaction, with FMC's stock declining 4.41%.
FMC Corporation 8-K Filing Analysis
FMC Corporation has released its 8-K filing, detailing a challenging financial performance for Q4 and full-year 2025, including a significant net loss due to goodwill impairment. The company is pursuing strategic initiatives for 2026, such as debt reduction through asset sales and improving its product portfolio, while also exploring a potential sale of the company to enhance shareholder value. Despite these efforts, FMC anticipates a decline in revenue, Adjusted EBITDA, and Adjusted EPS for 2026.
FMC explores strategic options as it reports 2025 results
FMC Corporation is exploring strategic options, including a potential sale, after reporting a significant net loss of $2.24 billion in 2025 and an 18% decrease in revenue. The company plans to strengthen its balance sheet by reducing $1 billion in debt through asset sales and licensing agreements in 2026, despite a forecast of continued revenue and EBITDA decline. Analysts tracked by InvestingPro predict a return to profitability in 2026, but the company faces challenges with declining sales and a recent credit downgrade.
FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company
FMC Corporation has announced its 2026 priorities, which include strengthening its balance sheet, improving its core portfolio, managing the post-patent strategy for Rynaxypyr®, and supporting new active ingredients. Concurrently, the company's Board of Directors has authorized the exploration of strategic options, including a potential sale of the company, to enhance shareholder value and ensure long-term success for its growth and core assets. This strategic review is in its early stages, and there is no guarantee of a transaction.
FMC Corporation (FMC) Fell After Disappointing Results
Pzena Focused Value Strategy's Q4 2025 commentary highlighted FMC Corporation (NYSE:FMC) as a significant detractor due to disappointing third-quarter results, revised guidance, and a dividend cut. The agricultural science company's stock closed at $15.80, down 71.23% over the past year, attributed to delayed customer collections in Brazil, the sale of its India business, and increased generic competition. Despite its underperformance in a strong AI momentum market, Pzena still sees value for long-term investors, although Insider Monkey suggests more promising AI stocks.
FMC Corp stock: chemical slump, cautious hope as Wall Street recalibrates
FMC Corp (FMC) stock is experiencing a downturn due to reduced crop chemical demand and farmer spending, with its price significantly below 52-week highs. Despite a recent modest bounce suggesting potential stabilization, Wall Street analysts remain cautious, maintaining neutral ratings but trimming price targets. The company's future hinges on the pace of channel destocking, agricultural commodity prices, and successful cost-cutting initiatives.
Agriculture Operations Earnings Roster Next Week: ADM, ALCO, CTVA, FMC
This article previews the upcoming fourth-quarter 2025 earnings reports for several agriculture operation companies: Archer Daniels Midland (ADM), Alico (ALCO), Corteva (CTVA), and FMC Corporation (FMC). It highlights the challenges faced by the agriculture sector, including lower farm income and high input costs, but also points to the potential benefits of innovation and cost-saving measures. The author provides a brief analysis of each company, including their respective Zacks Ranks and Earnings ESPs, to predict potential earnings surprises.
Barclays Maintains FMC Corp(FMC.US) With Sell Rating, Maintains Target Price $13
Barclays analyst Benjamin Theurer has maintained a "sell" rating on FMC Corp (FMC.US) and kept the target price at $13. According to TipRanks data, the analyst has a 51.0% success rate and a 3.9% average return over the past year. TipRanks provides independent analysis data for financial analysts, calculating average returns and success rates based on virtual portfolio performance.
Barclays Maintains FMC Corp(FMC.US) With Sell Rating, Maintains Target Price $13
Barclays analyst Benjamin Theurer has reiterated a Sell rating on FMC Corp (FMC.US), maintaining a target price of $13. According to TipRanks data, the analyst has a 51.0% success rate and a 3.9% average return over the past year. This rating is based on an independent third-party analysis by TipRanks, which tracks analyst performance.
Earnings Preview: FMC (FMC) Q4 Earnings Expected to Decline
FMC (FMC) is expected to report a year-over-year decline in earnings and lower revenues for the quarter ended December 2025, with an expected earnings per share of $1.21. The Zacks Earnings ESP indicates a negative surprise for FMC, though the company has a strong history of beating EPS estimates. Investors should also consider other factors beyond the earnings report for insights into the stock's future performance.
FMC's 2026 stockholder meeting will be webcast live on April 28
FMC Corporation announced its 2026 Annual Meeting of Stockholders will be held via live webcast on Tuesday, April 28, 2026, at 2:00 p.m. ET. The record date for determining eligible stockholders to vote is Friday, February 27, 2026. Further details, including webcast instructions, will be provided in the proxy statement on the company's Investor Relations website.
FMC Corporation Announces Date of 2026 Annual Meeting of Stockholders
FMC Corporation announced that its 2026 Annual Meeting of Stockholders will be held via live webcast on Tuesday, April 28, 2026, at 2:00 p.m. ET. The record date for determining stockholders entitled to vote is Friday, February 27, 2026. Further details will be provided in proxy materials available on the company's Investor Relations website.
FMC Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
The article reports that FMC Corp. stock underperformed on Wednesday compared to its competitors, despite daily gains. It also includes partial financial results for Unity Software (U.US), stating that its fourth-quarter revenue increased 35% year-over-year to $609 million, beating analyst estimates, although the company reported a quarterly loss of 66 cents per share. The full article content is behind a login wall, limiting further details.
FMC Receives Neutral Rating with Raised Price Target from Citigr
Citigroup maintained a Neutral rating for FMC (FMC) and raised its price target from $14.00 to $16.00 USD, reflecting a 14.29% increase. This rating suggests the analyst expects the stock to perform in line with the broader market. Wall Street analysts currently project an average target price of $22.55 for FMC, implying a potential upside of 43.83% from its current price, while GuruFocus estimates the fair value (GF Value) at $53.81.
FMC Corp Stock: Deep-Value Play or Value Trap? What Wall Street Is Really Pricing In
FMC Corp's stock has seen a significant downturn over the past year due to collapsing crop-chemical prices and excess inventory, leading investors to question if its recent rebound is a genuine recovery or a "dead-cat bounce." While Wall Street analysts have a cautiously constructive outlook, with price targets implying moderate upside, the company's future hinges on its ability to execute cost-cutting measures, innovate with differentiated active ingredients, and navigate a challenging regulatory environment. Investors are looking for tangible proof that the downcycle is fading and that FMC's innovation engine can translate into resilient cash flows.
FMC Corp Is Quietly Exploding: Is This ‘Boring’ Stock the Next Big Money Cheat Code?
FMC Corp, a global agricultural sciences company, is gaining attention as a potential rebound play despite a recent downturn. While not a meme stock, its focus on crop protection and agricultural technologies positions it in a growing food demand sector, attracting risk-tolerant investors looking for long-term recovery stories. Investors are advised to consider its volatility, dividend sustainability, and the broader agricultural market trends before investing.
FMC Corp Is Quietly Exploding: Is This ‘Boring’ Stock the Next Big Money Cheat Code?
FMC Corp, an agricultural and crop-tech company, is being highlighted as a potential rebound play despite a recent downturn. The article discusses its role in crop protection, its stock price volatility, and its dividend program, comparing it to competitors like Corteva and Bayer. It concludes that FMC is a high-risk, high-volatility speculative play for investors comfortable with thorough research and a multi-year recovery strategy.
Ignore FMC Stock: This Agricultural Innovator Is Reaping Rewards From AI and Automation
Deere & Company is leading the agricultural revolution by integrating AI and automation into farming, including smart sprayers and autonomous tractors, which significantly reduce pesticide use and improve efficiency. While Deere shows promising growth and technological advancement despite a challenging 2025, FMC Corporation, a chemical producer, faces substantial revenue and income decline due to reduced demand for pesticides, making Deere a more attractive investment.
FMC Canada unveils 2026 crop protection roster
FMC Canada has announced its 2026 crop protection lineup, featuring four new products specifically marketed for controlling kochia and other herbicide-resistant weeds. Key introductions include Avireo, a pre-seed/pre-emergent herbicide, Barricade III, a post-emergent herbicide, and PrecisionPac CF-18-878 Pro, a burnoff blend. The company also introduced Avoda Pro seed treatment, Focus NXT herbicide, and Optimize FXC DS soybean innoculant.
Why FMC Corporation Plunged 72% in 2025
FMC Corporation's stock plunged 71.5% in 2025 due to missed revenue expectations, the expiration of key chemical patents, high interest rates affecting South American clients, and a significant 86% dividend cut. The company is undergoing a "reset year" with divestitures and cost cuts, aiming for a turnaround by 2028 when new patent-protected products are expected. Investors are advised to watch for the India business sale and improved cash collections, as the company grapples with a substantial debt load and a cyclical industry.
FMC Analyst Rating Update: Mizuho Lowers Price Target | FMC Stoc
Mizuho has maintained its "Outperform" rating for FMC but reduced its price target from $24.00 to $21.00, a 12.50% decrease. This update follows a series of recent analyst downgrades and price target reductions for FMC from other firms like UBS, Citigroup, Barclays, and JP Morgan. Despite these adjustments, the average Wall Street target price of $22.55 implies a 45.64% upside from the current price, while GuruFocus estimates a fair value of $53.81, suggesting a 247.61% upside.
FMC Corporation Shares Plunge 71.5% in 2025 Amid Restructuring Challenges
FMC Corporation's shares plummeted 71.5% in 2025 due to significant revenue and profit declines, high interest rates, and expiring patents, leading to a drastic dividend cut. CEO Pierre Brondeau initiated a "reset year" with cost reduction plans, direct sales focus, and the sale of its India business to address over $4.5 billion in debt. Despite restructuring efforts and consolidation of manufacturing, the company faces continued challenges, lacking new patent-protected products until 2028, and Wall Street analysts have issued several downgrades with lowered price targets.
Lobbying Update: $20,000 of FMC CORPORATION lobbying was just disclosed
FMC CORPORATION disclosed $20,000 in lobbying activity for Q4 2025, primarily focused on "Corporate Income Tax." The article also details recent congressional stock trades of FMC by Representative Lisa C. McClain, insider trading activity showing both purchases and sales, and significant movements in institutional holdings. Analyst ratings include "Outperform" and "Buy" with a median price target of $16.5 from 10 analysts.
FMC Corp extends credit facility to June 2028
FMC Corp (FMC) announced an extension to its revolving credit facility, pushing its maturity date from June 2024 to June 2028. This extension maintains the aggregate commitments at $1 billion, providing the company with continued financial flexibility.
FMC Corporation (FMC) balances earnings growth with plant closures and cost savings plan
FMC Corporation is taking strategic actions to enhance earnings growth. The company is closing specialty chemical plants in the Netherlands and the UK, reducing its global workforce by 3% to streamline its operational footprint. These measures are part of a broader cost savings plan expected to generate $50 million in annual savings by 2026.
